RADEK SKODA to Glutaminase
This is a "connection" page, showing publications RADEK SKODA has written about Glutaminase.
Connection Strength
0.891
-
The glutaminase inhibitor CB-839 targets metabolic dependencies of JAK2-mutant hematopoiesis in MPN. Blood Adv. 2024 05 14; 8(9):2312-2325.
Score: 0.891
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.